• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过时空回归和事后分层提高英国全国 COVID-19 感染调查的代表性。

Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratification.

机构信息

Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.

出版信息

Nat Commun. 2024 Jun 24;15(1):5340. doi: 10.1038/s41467-024-49201-4.

DOI:10.1038/s41467-024-49201-4
PMID:38914564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11196632/
Abstract

Population-representative estimates of SARS-CoV-2 infection prevalence and antibody levels in specific geographic areas at different time points are needed to optimise policy responses. However, even population-wide surveys are potentially impacted by biases arising from differences in participation rates across key groups. Here, we used spatio-temporal regression and post-stratification models to UK's national COVID-19 Infection Survey (CIS) to obtain representative estimates of PCR positivity (6,496,052 tests) and antibody prevalence (1,941,333 tests) for different regions, ages and ethnicities (7-December-2020 to 4-May-2022). Not accounting for vaccination status through post-stratification led to small underestimation of PCR positivity, but more substantial overestimations of antibody levels in the population (up to 21 percentage points), particularly in groups with low vaccine uptake in the general population. There was marked variation in the relative contribution of different areas and age-groups to each wave. Future analyses of infectious disease surveys should take into account major drivers of outcomes of interest that may also influence participation, with vaccination being an important factor to consider.

摘要

需要对特定地理区域在不同时间点的 SARS-CoV-2 感染流行率和抗体水平进行具有代表性的估计,以优化政策应对措施。然而,即使是在全人群中进行的调查,也可能受到不同关键群体参与率差异带来的偏差的影响。在这里,我们使用时空回归和后分层模型对英国国家 COVID-19 感染调查(CIS)进行分析,以获得不同地区、年龄和族裔(2020 年 12 月 7 日至 2022 年 5 月 4 日)的 PCR 阳性率(6,496,052 次检测)和抗体流行率(1,941,333 次检测)的代表性估计。通过后分层不考虑疫苗接种状态会导致 PCR 阳性率的低估,但会对人群中的抗体水平产生更大的高估(高达 21 个百分点),特别是在一般人群中疫苗接种率较低的群体中。不同地区和年龄组对每一波的相对贡献存在明显差异。未来对传染病调查的分析应考虑可能影响参与的重要结果驱动因素,其中疫苗接种是一个需要考虑的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144d/11196632/de0489b14199/41467_2024_49201_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144d/11196632/3e52374a61c9/41467_2024_49201_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144d/11196632/303518786e88/41467_2024_49201_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144d/11196632/08f98bdc4e1d/41467_2024_49201_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144d/11196632/de0489b14199/41467_2024_49201_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144d/11196632/3e52374a61c9/41467_2024_49201_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144d/11196632/303518786e88/41467_2024_49201_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144d/11196632/08f98bdc4e1d/41467_2024_49201_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144d/11196632/de0489b14199/41467_2024_49201_Fig4_HTML.jpg

相似文献

1
Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratification.通过时空回归和事后分层提高英国全国 COVID-19 感染调查的代表性。
Nat Commun. 2024 Jun 24;15(1):5340. doi: 10.1038/s41467-024-49201-4.
2
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.加拿大艾伯塔省 COVID-19 大流行前两波期间 SARS-CoV-2 抗体的预疫苗阳性率。
Microbiol Spectr. 2021 Sep 3;9(1):e0029121. doi: 10.1128/Spectrum.00291-21. Epub 2021 Aug 18.
3
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.BNT162b2 新冠病毒疫苗与体液免疫应答及动力学的相关性:医护人员前瞻性、单中心、纵向队列研究。
Lancet Respir Med. 2021 Sep;9(9):999-1009. doi: 10.1016/S2213-2600(21)00220-4. Epub 2021 Jul 2.
4
Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.在一个大型综合医疗体系中,COVID-19 疫苗接种和 SARS-CoV-2 感染对 SARS-CoV-2 刺突抗体人群血清阳性率的相对贡献。
PLoS One. 2024 Jun 20;19(6):e0303303. doi: 10.1371/journal.pone.0303303. eCollection 2024.
5
Differential COVID-19 case ascertainment by age and vaccination status in Victoria, Australia: a serosurveillance and record linkage study.澳大利亚维多利亚州按年龄和疫苗接种状况对 COVID-19 病例进行差异判定:血清学监测和记录链接研究。
Commun Dis Intell (2018). 2024 Aug 21;48. doi: 10.33321/cdi.2024.48.28.
6
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率:哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
7
Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study.加纳成年人在完成新冠疫苗基础免疫后产生的中和抗体滴度高于且比英国匹配的成年人更持久:HERITAGE研究。
BMC Med. 2025 May 28;23(1):312. doi: 10.1186/s12916-025-04157-0.
8
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.英国针对新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的免疫反应实时估计:一项数学建模研究
Lancet Infect Dis. 2025 Jan;25(1):80-93. doi: 10.1016/S1473-3099(24)00484-5. Epub 2024 Sep 11.
9
Spatio-temporal distributions of COVID-19 vaccine doses uptake in the Netherlands: a Bayesian ecological modelling analysis.荷兰 COVID-19 疫苗接种剂量的时空分布:贝叶斯生态建模分析。
Epidemiol Infect. 2024 Oct 7;152:e119. doi: 10.1017/S0950268824001249.
10
The Second Round of a Population-Based Seroprevalence Study of Anti-SARS-CoV-2 Antibodies and COVID-19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina.波斯尼亚和黑塞哥维那斯普斯卡共和国第二轮基于人群的抗SARS-CoV-2抗体血清流行率研究及新冠疫苗接种评估
Influenza Other Respir Viruses. 2025 Jan;19(1):e70053. doi: 10.1111/irv.70053.

引用本文的文献

1
Did COVID-19 surveillance system sensitivity change after Omicron? a retrospective observational study in England.奥密克戎毒株出现后,新冠病毒监测系统的敏感性发生变化了吗?一项在英国开展的回顾性观察研究。
BMC Infect Dis. 2025 May 29;25(1):770. doi: 10.1186/s12879-025-11120-0.
2
A Texting- and Internet-Based Self-Reporting System for Enhanced Vaccine Safety Surveillance With Insights From a Large Integrated Health Care System in the United States: Prospective Cohort Study.基于短信和互联网的自我报告系统增强疫苗安全性监测:来自美国大型综合医疗保健系统的见解:前瞻性队列研究。
JMIR Mhealth Uhealth. 2024 Oct 11;12:e58991. doi: 10.2196/58991.

本文引用的文献

1
An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalence.对英格兰 45 个大型废水站点进行分析,以估计 SARS-CoV-2 社区流行率。
Nat Commun. 2022 Jul 25;13(1):4313. doi: 10.1038/s41467-022-31753-y.
2
Improving multilevel regression and poststratification with structured priors.使用结构化先验改进多层回归和事后分层。
Bayesian Anal. 2021 Sep;16(3):719-744. doi: 10.1214/20-ba1223. Epub 2020 Jul 15.
3
The effectiveness of incentives for research participation: A systematic review and meta-analysis of randomized controlled trials.
激励研究参与的有效性:随机对照试验的系统评价和荟萃分析。
PLoS One. 2022 Apr 22;17(4):e0267534. doi: 10.1371/journal.pone.0267534. eCollection 2022.
4
Beyond Vaccination Rates: A Synthetic Random Proxy Metric of Total SARS-CoV-2 Immunity Seroprevalence in the Community.超越疫苗接种率:社区中 SARS-CoV-2 总免疫血清流行率的综合随机代理指标。
Epidemiology. 2022 Jul 1;33(4):457-464. doi: 10.1097/EDE.0000000000001488. Epub 2022 Mar 29.
5
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines.在接种两剂 ChAdOx1 或 BNT162b2 疫苗后,普通人群中的抗体反应和保护相关因素。
Nat Med. 2022 May;28(5):1072-1082. doi: 10.1038/s41591-022-01721-6. Epub 2022 Feb 14.
6
Improving local prevalence estimates of SARS-CoV-2 infections using a causal debiasing framework.利用因果去偏框架提高 SARS-CoV-2 感染的本地流行率估计。
Nat Microbiol. 2022 Jan;7(1):97-107. doi: 10.1038/s41564-021-01029-0. Epub 2021 Dec 31.
7
Unrepresentative big surveys significantly overestimated US vaccine uptake.不具代表性的大型调查显著高估了美国的疫苗接种率。
Nature. 2021 Dec;600(7890):695-700. doi: 10.1038/s41586-021-04198-4. Epub 2021 Dec 8.
8
Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients’ primary care records in situ using OpenSAFELY.利用 OpenSAFELY 在原地对 5790 万患者的初级保健记录进行的联邦分析显示,COVID-19 疫苗接种者的趋势和临床特征。
Br J Gen Pract. 2021 Dec 31;72(714):e51-e62. doi: 10.3399/BJGP.2021.0376. Print 2022 Jan.
9
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK.德尔塔变异株对英国新冠病毒载量及针对新型严重急性呼吸综合征冠状病毒2感染的疫苗效力的影响。
Nat Med. 2021 Dec;27(12):2127-2135. doi: 10.1038/s41591-021-01548-7. Epub 2021 Oct 14.
10
Routine Hospital-based SARS-CoV-2 Testing Outperforms State-based Data in Predicting Clinical Burden.基于医院的常规 SARS-CoV-2 检测在预测临床负担方面优于基于州的数据。
Epidemiology. 2021 Nov 1;32(6):792-799. doi: 10.1097/EDE.0000000000001396.